RESEARCH-USE BIOSIMILAR ANTIBODY

Coltuximab

Antibody-drug conjugate · IgG1

CD19IgG1RUO

Coltuximab is a CHO-expressed humanized antibody that targets CD19. Coltuximab is composed of huIgG1 heavy chains and huκ light chains, with a molecular weight (MW) of 144.70 kDa. The isotype control for Coltuximab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

TARGETCD19
YAntibody-drug conjugate
CATALOGSC-BS-654
CATALOG NUMBERSC-BS-654
MOLECULAR WEIGHTApprox. 144.7 kDa
PRODUCT FORMATAntibody-drug conjugate

A research-use configuration for comparative antibody studies

Coltuximab is a CHO-expressed humanized antibody that targets CD19. Coltuximab is composed of huIgG1 heavy chains and huκ light chains, with a molecular weight (MW) of 144.70 kDa. The isotype control for Coltuximab can refer to Human IgG1 kappa, Isotype Control (HY-P99001).

Coltuximab is a recombinant research-use antibody directed against CD19.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Coltuximab | StellaCyte